PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Gottlieb to Face User Fees, De-Regulation Pressures

Affordability: An Unpopular NICE and NHSE Approach

What First Amendment? FDA Remains Unfazed By Off-Label Communication Issues

Technology
Big Data: Is It Crunch Time for Pharma?
With big data one of the hot healthcare topics of the moment, we gauge pharma's response to the hype to see if the industry is poised to take advantage of the promise of advanced analytics.
... /Read more/
Market Access
Setting Sights on the Smart Supply Chain
Amid the push for a more intelligent and predictive supply chain, is it imperative for pharma companies to advance with their supply chain digitization strategies now—or is there still time to "wait and see?"
... /Read more/
Emerging Markets
Biotech Roundtable: The Quest for Translation
Facing mixed market signals, biotech companies look to rise above the fray in advancing new-wave discoveries to the clinical finish line.
... /Read more/
Technology
Precision Medicine and Big Data
How integrating next-generation sequencing data can advance efforts in immuno-oncology research.
... /Read more/
Technology
Big Money and Big Data
No longer just hype, investing in big data is the path to the future for pharma, even if big returns aren't a direct result, writes Pharm Exec Editor Lisa Henderson.
... /Read more/
Calendar
 
/ DCAT Week ’17 3/20-3/23 /
 
/ West Coast Medical Education & Research Grants Breakthrough Summit 4/4-4/5 /
 
/ 7th Annual Global Transparency Reporting Congress 4/4-4/5 /
 
 
update my profile / advertise with us / print & digital subscribe / visit pharmexec.com